These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 38744287)

  • 21. Prime Editing in Mammals: The Next Generation of Precision Genome Editing.
    Wang D; Fan X; Li M; Liu T; Lu P; Wang G; Li Y; Han J; Zhao J
    CRISPR J; 2022 Dec; 5(6):746-768. PubMed ID: 36512351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward precise CRISPR DNA fragment editing and predictable 3D genome engineering.
    Wu Q; Shou J
    J Mol Cell Biol; 2021 Feb; 12(11):828-856. PubMed ID: 33125070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent Advances in Genome-Engineering Strategies.
    Boti MA; Athanasopoulou K; Adamopoulos PG; Sideris DC; Scorilas A
    Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The big bang of genome editing technology: development and application of the CRISPR/Cas9 system in disease animal models.
    Shao M; Xu TR; Chen CS
    Dongwuxue Yanjiu; 2016 Jul; 37(4):191-204. PubMed ID: 27469250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Tale of Two Moieties: Rapidly Evolving CRISPR/Cas-Based Genome Editing.
    Yang L; Chen J
    Trends Biochem Sci; 2020 Oct; 45(10):874-888. PubMed ID: 32616331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo application of base and prime editing to treat inherited retinal diseases.
    Jo DH; Bae S; Kim HH; Kim JS; Kim JH
    Prog Retin Eye Res; 2023 May; 94():101132. PubMed ID: 36241547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Base editing the mammalian genome.
    Schatoff EM; Zafra MP; Dow LE
    Methods; 2019 Jul; 164-165():100-108. PubMed ID: 30836137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvements in the genetic editing technologies: CRISPR-Cas and beyond.
    Mingarro G; Del Olmo ML
    Gene; 2023 Feb; 852():147064. PubMed ID: 36435506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging applications of genome-editing technology to examine functionality of GWAS-associated variants for complex traits.
    Smith AJP; Deloukas P; Munroe PB
    Physiol Genomics; 2018 Jul; 50(7):510-522. PubMed ID: 29652634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors.
    Anzalone AV; Koblan LW; Liu DR
    Nat Biotechnol; 2020 Jul; 38(7):824-844. PubMed ID: 32572269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deconstructing cancer with precision genome editing.
    Johnson GA; Gould SI; Sánchez-Rivera FJ
    Biochem Soc Trans; 2024 Apr; 52(2):803-819. PubMed ID: 38629716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA base editing in nuclear and organellar genomes.
    Tan J; Forner J; Karcher D; Bock R
    Trends Genet; 2022 Nov; 38(11):1147-1169. PubMed ID: 35853769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AlleleProfileR: A versatile tool to identify and profile sequence variants in edited genomes.
    Bruyneel AAN; Colas AR; Karakikes I; Mercola M
    PLoS One; 2019; 14(12):e0226694. PubMed ID: 31877162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in CRISPR-based functional genomics for the study of disease-associated genetic variants.
    Kim HS; Kweon J; Kim Y
    Exp Mol Med; 2024 Apr; 56(4):861-869. PubMed ID: 38556550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prime editing: advances and therapeutic applications.
    Zhao Z; Shang P; Mohanraju P; Geijsen N
    Trends Biotechnol; 2023 Aug; 41(8):1000-1012. PubMed ID: 37002157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linking genome variants to disease: scalable approaches to test the functional impact of human mutations.
    Findlay GM
    Hum Mol Genet; 2021 Oct; 30(R2):R187-R197. PubMed ID: 34338757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation-specific reporter for optimization and enrichment of prime editing.
    Schene IF; Joore IP; Baijens JHL; Stevelink R; Kok G; Shehata S; Ilcken EF; Nieuwenhuis ECM; Bolhuis DP; van Rees RCM; Spelier SA; van der Doef HPJ; Beekman JM; Houwen RHJ; Nieuwenhuis EES; Fuchs SA
    Nat Commun; 2022 Mar; 13(1):1028. PubMed ID: 35232966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prime editing: Its systematic optimization and current applications in disease treatment and agricultural breeding.
    Yu X; Huo G; Yu J; Li H; Li J
    Int J Biol Macromol; 2023 Dec; 253(Pt 4):127025. PubMed ID: 37769783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional Genomics of
    Wambach JA; Yang P; Wegner DJ; Heins HB; Luke C; Li F; White FV; Cole FS
    Am J Respir Cell Mol Biol; 2020 Oct; 63(4):436-443. PubMed ID: 32692933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methods for Optimizing CRISPR-Cas9 Genome Editing Specificity.
    Tycko J; Myer VE; Hsu PD
    Mol Cell; 2016 Aug; 63(3):355-70. PubMed ID: 27494557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.